ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INBX)

13.58
0.03
(0.22%)
Closed February 01 4:00PM
13.47
-0.11
(-0.81%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
13.58
Bid
5.41
Ask
13.98
Volume
230,867
13.25 Day's Range 13.97
10.80 52 Week Range 39.79
Market Cap
Previous Close
13.55
Open
13.805
Last Trade
1
@
13.58
Last Trade Time
Financial Volume
$ 3,114,959
VWAP
13.4924
Average Volume (3m)
82,826
Shares Outstanding
14,475,904
Dividend Yield
-
PE Ratio
-1.26
Earnings Per Share (EPS)
-10.71
Revenue
1.63M
Net Profit
-154.96M

About Inhibrx Biosciences Inc

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was $13.55. Over the last year, Inhibrx Biosciences shares have traded in a share price range of $ 10.80 to $ 39.79.

Inhibrx Biosciences currently has 14,475,904 shares outstanding. The market capitalization of Inhibrx Biosciences is $196.15 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.26.

INBX Latest News

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer PR Newswire SAN DIEGO, Jan. 21, 2025 SAN DIEGO, Jan. 21, 2025...

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance PR Newswire SAN DIEGO, Jan. 13, 2025 SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. ("Inhibrx" or the...

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.634.8648648648612.9514.12511.7911506113.01369446CS
4-1.73-11.299804049615.3116.8311.798929913.68469968CS
12-2.57-15.913312693516.1517.4111.798282614.41653048CS
26-0.65-4.5678144764614.2317.7910.88809414.67058319CS
52-25.03-64.827764827838.6139.7910.828377829.44373769CS
156-11.45-45.74510587325.0339.797.6741945624.91706561CS
260-6.12-31.065989847719.750.977.6733719525.80950303CS

INBX - Frequently Asked Questions (FAQ)

What is the current Inhibrx Biosciences share price?
The current share price of Inhibrx Biosciences is $ 13.58
How many Inhibrx Biosciences shares are in issue?
Inhibrx Biosciences has 14,475,904 shares in issue
What is the market cap of Inhibrx Biosciences?
The market capitalisation of Inhibrx Biosciences is USD 196.15M
What is the 1 year trading range for Inhibrx Biosciences share price?
Inhibrx Biosciences has traded in the range of $ 10.80 to $ 39.79 during the past year
What is the PE ratio of Inhibrx Biosciences?
The price to earnings ratio of Inhibrx Biosciences is -1.26
What is the cash to sales ratio of Inhibrx Biosciences?
The cash to sales ratio of Inhibrx Biosciences is 119.31
What is the reporting currency for Inhibrx Biosciences?
Inhibrx Biosciences reports financial results in USD
What is the latest annual turnover for Inhibrx Biosciences?
The latest annual turnover of Inhibrx Biosciences is USD 1.63M
What is the latest annual profit for Inhibrx Biosciences?
The latest annual profit of Inhibrx Biosciences is USD -154.96M
What is the registered address of Inhibrx Biosciences?
The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Inhibrx Biosciences website address?
The website address for Inhibrx Biosciences is www.inhibrx.com
Which industry sector does Inhibrx Biosciences operate in?
Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCTMTCTM Kids IT Education Inc
$ 0.764
(321.87%)
731.1M
REBNReborn Coffee Inc
$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
$ 1.54
(56.50%)
13.87M
CYCNCyclerion Therapeutics Inc
$ 3.92
(54.33%)
82.57M
ENVBEnveric Biosciences Inc
$ 2.0899
(-46.41%)
1.58M
NIVFNewGenIvf Group Ltd
$ 0.1489
(-42.51%)
14.91M
GLSTGlobal Star Acquisition Inc
$ 8.83
(-39.10%)
23.93k
PRPHProPhase Labs Inc
$ 0.2633
(-38.02%)
900.48k
SPGCSacks Parente Golf Inc
$ 0.5601
(-37.86%)
7.42M
TCTMTCTM Kids IT Education Inc
$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0355
(-11.25%)
236.44M

Discussion

View Full Feed
No Posts Found

Your Recent History

Delayed Upgrade Clock